Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.095 USD | +1.39% | -2.68% | +25.62% |
Evolution of the average Target Price on Unicycive Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Unicycive Therapeutics, Inc.
Piper Sandler | |
HC Wainwright | |
Roth MKM | |
Maxim | |
EF Hutton | |
Benchmark Capital | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- UNCY Stock
- Consensus Unicycive Therapeutics, Inc.